Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut–Liver In Vitro Model
Molecules · 2026
DOI: 10.3390/molecules31183265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Simone Mulè und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale, Piazza Sant'Eusebio 5, 13100 Vercelli, Italy. Hauptthemen laut MEDLINE: Ubiquinone, Cholesterol, Liver, Cordyceps. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dysregulated hepatic cholesterol handling and oxidative stress represent key targets for nutritional interventions. This study investigated a combination of Ophiocordyceps sinensis (formerly Cordyceps sinensis) extract and coenzyme Q10 (CoQ10) using a sequential gut–liver in vitro model. Differentiated Caco-2/HT29-MTX co-cultures were used to assess intestinal transport, transepithelial electrical resistance (TEER), and junctional organisation. The resulting basolateral intestinal-conditioned medium was applied to high-glucose-stressed HepG2 cells. The combined treatment-maintained epithelial electrical integrity (TEER > 400 Ω·cm2) and tight junction protein abundance, while transiently increasing paracellular fluorescein transport (Papp) and enhancing basolateral CoQ10 recovery (+29%). In HepG2 cells, the conditioned medium reduced superoxide production (−38%) and enhanced both DiI-labelled low-density lipoprotein (DiI-LDL) uptake (+26%) and intracellular total bile acid content (+33%). These functional outcomes were accompanied by coordinated changes in protein abundance: a decrease in sterol regulatory element-binding protein 2 (SREBP-2), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels, alongside increased low-density lipoprotein receptor (LDLR), cytochrome P450 family 7 subfamily A member 1 (CYP7A1), and ATP-binding cassette transporter A1 (ABCA1) expression. Pharmacological inhibition with dorsomorphin suggested a partial involvement of AMP-activated protein kinase (AMPK) signalling, although this mechanistic assessment remained exploratory. Overall, these findings demonstrate the coordinated modulation of intestinal transport, functional hepatic endpoints, and cholesterol-related protein abundance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale, Piazza Sant'Eusebio 5, 13100 Vercelli, Italy.
- Noivita s.r.l.s., Spin Off of University of Piemonte Orientale, Strada Privata Curti n. 7, 28100 Novara, Italy.
ORCID-Profile: Francesca Uberti
Zitieren
APA
Mulè, S., Galla, R., Musu, M., Parini, F., Molinari, C., & Uberti, F. (2026). Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut–Liver In Vitro Model. Molecules. https://doi.org/10.3390/molecules31183265
Vancouver
Mulè S, Galla R, Musu M, Parini F, Molinari C, Uberti F. Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut–Liver In Vitro Model. Molecules. 2026. doi:10.3390/molecules31183265
BibTeX
@article{Mul2026,
author = {Mulè, Simone and Galla, Rebecca and Musu, Matteo and Parini, Francesca and Molinari, Claudio and Uberti, Francesca},
title = {Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut–Liver In Vitro Model},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31183265}
}
EUVIMED